Skip NavigationSkip to Content

Degradation of the Met Tyrosine Kinase Receptor By the Ubiquitin-Proteasome Pathway

  1. Author:
    Jeffers, M.
    Taylor, G. A.
    Weidner, K. M.
    Omura, S.
    Vande Woude, G. F
  2. Author Address

    Vandewoude GF NCI FREDERICK CANC RES & DEV CTR ABL BASIC RES PROGRAM POB B BLDG 469 ROOM 246 FREDERICK, MD 21702 USA NCI FREDERICK CANC RES & DEV CTR ABL BASIC RES PROGRAM FREDERICK, MD 21702 USA MAX DELBRUCK CTR MOL MED D-13125 BERLIN GERMANY KITASATO INST BIOL FUNCT RES CTR TOKYO 108 JAPAN
    1. Year: 1997
  1. Journal: Molecular and Cellular Biology
    1. 17
    2. 2
    3. Pages: 799-808
  2. Type of Article: Article
  1. Abstract:

    The Met tyrosine kinase receptor is a widely expressed molecule which mediates pleiotropic cellular responses following activation by its ligand, hepatocyte growth factor/scatter factor (HGF/SF). In this communication we demonstrate that significant Met degradation is induced by HGF/SF and that this degradation can be blocked by lactacystin, an inhibitor of proteasome activity. We also show that Met is rapidly polyubiquitinated in response to ligand and that polyubiquitinated Met molecules, which are normally unstable, are stabilized by lactacystin. Both HGF/SF-induced degradation and polyubiquitination of Met were shown to be dependent on the receptor possessing intact tyrosine kinase activity. Finally, we found that a normally highly labile 55-kDa fragment of the Met receptor is stabilized by lactacystin and demonstrate that it represents a cell-associated remnant that is generated following the ligand-independent proteolytic cleavage of the Met receptor in its extracellular domain. This truncated Met molecule encompasses the kinase domain of the receptor and is itself tyrosine phosphorylated. We conclude that the ubiquitin-proteasome pathway plays a significant role in the degradation of the Met tyrosine kinase receptor as directed by ligand-dependent and -independent signals. We propose that this proteolytic pathway may be important for averting cellular transformation by desensitizing Met signaling following ligand stimulation and by eliminating potentially oncogenic fragments generated via extracellular cleavage of the Met receptor. [References: 68]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel